I am a
Home I AM A Search Login

Papers of the Week

2022 Feb 08

Diabetes Metab Syndr



Efficacy and safety of long-acting growth hormone in adult growth hormone deficiency: A systematic review and meta-analysis.


Dutta D, Mahajan K, Kumar M, Sharma M
Diabetes Metab Syndr. 2022 Feb 08; 16(2):102421.
PMID: 35158212.


No meta-analysis has analysed efficacy and safety of long-acting growth hormone (GH) therapy in adult GH deficiency. We undertook this meta-analysis to address this gap in knowledge METHODS: Electronic databases were searched for RCTs involving adult GH deficiency patients receiving weekly long-acting GH as compared to daily GH/placebo controls. Primary outcome was to evaluate changes in body-composition parameters. Secondary outcomes were to evaluate alterations in glycaemia and adverse-events.